Topics in Current Chemistry,
Год журнала:
2021,
Номер
379(6)
Опубликована: Окт. 8, 2021
The
highly
infectious
disease
COVID-19
is
induced
by
SARS-coronavirus
2
(SARS-CoV-2),
which
has
spread
rapidly
around
the
globe
and
was
announced
as
a
pandemic
World
Health
Organization
(WHO)
in
March
2020.
SARS-CoV-2
binds
to
host
cell's
angiotensin
converting
enzyme
(ACE2)
receptor
through
viral
surface
spike
glycoprotein
(S-protein).
ACE2
expressed
oral
mucosa
can
therefore
constitute
an
essential
route
for
entry
of
into
hosts
tongue
lung
epithelial
cells.
At
present,
no
effective
treatments
are
yet
place.
Blocking
virus
inhibiting
more
advantageous
than
subsequent
stages
life
cycle.
Based
on
current
published
evidence,
we
have
summarized
different
silico
based
studies
repurposing
anti-viral
drugs
target
ACE2,
S-Protein:
S-RBD:
ACE2.
This
review
will
be
useful
researchers
looking
effectively
recognize
deal
with
SARS-CoV-2,
development
repurposed
inhibitors
against
COVID-19.
Informatics in Medicine Unlocked,
Год журнала:
2022,
Номер
29, С. 100880 - 100880
Опубликована: Янв. 1, 2022
With
the
financial
requirements
and
high
time
associated
with
bringing
a
commercial
drug
to
market,
application
of
computer-aided
design
has
been
recognized
as
powerful
technology
in
discovery
pipeline.
In
accelerating
discovery,
molecular
modeling
techniques
have
experienced
considerable
growth
computational
capabilities
over
last
decade.
Pharmaceutical
companies
academic
research
organizations
are
currently
using
various
lower
cost
required
for
an
effective
drug.
this
article,
we
focus
on
reviewing
three
key
components
(Molecular
Docking,
Molecular
Dynamics,
ADMET
modeling),
their
applications,
limitations
small-molecule
discovery.
We
discussed
technicalities
encircling
dynamics
docking,
algorithms
used
develop
docking
softwares,
models
explored
by
these
coupled
scoring
functions.
also
reviewed
influence
simulations
(all
atoms
coarse-grained
simulations)
elucidated
how
ensembles
generated
from
MD
could
pave
way
novel
Furthermore,
briefly
explain
role
played
pharmacokinetics
pharmacodynamics
profiling
discovering
new
leads
therapeutic
efficacy.
Besides
success
highlighted
experimental
corroboration
silico
discovered
candidates.
However,
there
is
hardly
market
primarily
use
modeling,
concluded
review
proposing
possible
solutions
that
foster
advancement
clinical
drugs.
Chemical Society Reviews,
Год журнала:
2021,
Номер
50(16), С. 9121 - 9151
Опубликована: Янв. 1, 2021
COVID-19
has
resulted
in
huge
numbers
of
infections
and
deaths
worldwide
brought
the
most
severe
disruptions
to
societies
economies
since
Great
Depression.
Massive
experimental
computational
research
effort
understand
characterize
disease
rapidly
develop
diagnostics,
vaccines,
drugs
emerged
response
this
devastating
pandemic
more
than
130
000
COVID-19-related
papers
have
been
published
peer-reviewed
journals
or
deposited
preprint
servers.
Much
focused
on
discovery
novel
drug
candidates
repurposing
existing
against
COVID-19,
many
such
projects
either
exclusively
computer-aided
studies.
Herein,
we
provide
an
expert
overview
key
methods
their
applications
for
small-molecule
therapeutics
that
reported
literature.
We
further
outline
that,
after
first
year
pandemic,
it
appears
not
produced
rapid
global
solutions.
However,
several
known
used
clinic
cure
patients,
a
few
repurposed
continue
be
considered
clinical
trials,
along
with
candidates.
posit
truly
impactful
tools
must
deliver
actionable,
experimentally
testable
hypotheses
enabling
combinations,
open
science
sharing
results
are
critical
accelerate
development
novel,
much
needed
COVID-19.
Journal of Chemical Information and Modeling,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 5, 2025
Knowledge
of
the
structures
formed
by
proteins
and
small
molecules
is
key
to
understand
molecular
principles
chemotherapy
for
designing
new
more
effective
drugs.
During
early
stage
a
drug
discovery
program,
it
customary
predict
ligand-protein
complexes
in
silico,
particularly
when
screening
large
compound
databases.
While
virtual
based
on
docking
widely
used
this
purpose,
generally
fails
mimicking
binding
events
associated
with
conformational
changes
protein,
latter
involve
multiple
domains.
In
work,
we
describe
methodology
generate
bound-like
conformations
very
flexible
allosteric
bearing
sites
exploiting
only
information
unbound
structure
putative
sites.
The
protocol
validated
paradigm
enzyme
adenylate
kinase,
which
generated
significant
fraction
structures.
A
these
conformations,
employed
ensemble-docking
calculations,
allowed
find
native-like
poses
substrates
inhibitors
(binding
active
form
enzyme),
as
well
catalytically
incompetent
analogs
inactive
form).
Our
provides
general
framework
generation
challenging
targets
that
are
suitable
host
different
ligands,
demonstrating
high
sensitivity
fine
chemical
details
regulate
protein's
activity.
We
foresee
applications
screening,
prediction
impact
amino
acid
mutations
dynamics,
protein
engineering.
Chemical Science,
Год журнала:
2021,
Номер
12(22), С. 7866 - 7881
Опубликована: Янв. 1, 2021
Structure-based
virtual
screening
is
an
important
tool
in
early
stage
drug
discovery
that
scores
the
interactions
between
a
target
protein
and
candidate
ligands.
As
libraries
continue
to
grow
(in
excess
of
108
molecules),
so
too
do
resources
necessary
conduct
exhaustive
campaigns
on
these
libraries.
However,
Bayesian
optimization
techniques,
previously
employed
other
scientific
problems,
can
aid
their
exploration:
surrogate
structure-property
relationship
model
trained
predicted
affinities
subset
library
be
applied
remaining
members,
allowing
least
promising
compounds
excluded
from
evaluation.
In
this
study,
we
explore
application
techniques
computational
docking
datasets
assess
impact
architecture,
acquisition
function,
batch
size
performance.
We
observe
significant
reductions
costs;
for
example,
using
directed-message
passing
neural
network
identify
94.8%
or
89.3%
top-50
000
ligands
100M
member
after
testing
only
2.4%
upper
confidence
bound
greedy
strategy,
respectively.
Such
model-guided
searches
mitigate
increasing
costs
increasingly
large
accelerate
high-throughput
with
applications
beyond
docking.
Nature Computational Science,
Год журнала:
2021,
Номер
1(5), С. 321 - 331
Опубликована: Май 20, 2021
The
biomolecular
modeling
field
has
flourished
since
its
early
days
in
the
1970s
due
to
rapid
adaptation
and
tailoring
of
state-of-the-art
technology.
resulting
dramatic
increase
size
timespan
simulations
outpaced
Moore's
law.
Here,
we
discuss
role
knowledge-based
versus
physics-based
methods
hardware
software
advances
propelling
forward.
This
outreach
suggests
a
bright
future
for
modeling,
where
theory,
experimentation
simulation
define
three
pillars
needed
address
scientific
biomedical
challenges.
Journal of Chemical Information and Modeling,
Год журнала:
2021,
Номер
62(1), С. 116 - 128
Опубликована: Ноя. 18, 2021
Despite
the
recent
availability
of
vaccines
against
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
search
for
inhibitory
therapeutic
agents
has
assumed
importance
especially
in
context
emerging
new
viral
variants.
In
this
paper,
we
describe
discovery
a
novel
noncovalent
small-molecule
inhibitor,
MCULE-5948770040,
that
binds
to
and
inhibits
SARS-Cov-2
main
protease
(Mpro)
by
employing
scalable
high-throughput
virtual
screening
(HTVS)
framework
targeted
compound
library
over
6.5
million
molecules
could
be
readily
ordered
purchased.
Our
HTVS
leverages
U.S.
supercomputing
infrastructure
achieving
nearly
91%
resource
utilization
126
docking
calculations
per
hour.
Downstream
biochemical
assays
validate
Mpro
inhibitor
with
an
inhibition
constant
(Ki)
2.9
μM
(95%
CI
2.2,
4.0).
Furthermore,
using
room-temperature
X-ray
crystallography,
show
MCULE-5948770040
cleft
primary
binding
site
forming
stable
hydrogen
bond
hydrophobic
interactions.
We
then
used
multiple
μs-time
scale
molecular
dynamics
(MD)
simulations
machine
learning
(ML)
techniques
elucidate
how
bound
ligand
alters
conformational
states
accessed
Mpro,
involving
motions
both
proximal
distal
site.
Together,
our
results
demonstrate
offers
springboard
further
design.
Pathogens,
Год журнала:
2021,
Номер
10(8), С. 1048 - 1048
Опубликована: Авг. 18, 2021
As
of
August
6th,
2021,
the
World
Health
Organization
has
notified
200.8
million
laboratory-confirmed
infections
and
4.26
deaths
from
COVID-19,
making
it
worst
pandemic
since
1918
flu.
The
main
challenges
in
mitigating
COVID-19
are
effective
vaccination,
treatment,
agile
containment
strategies.
In
this
review,
we
focus
on
potential
Artificial
Intelligence
(AI)
surveillance,
diagnosis,
outcome
prediction,
drug
discovery
vaccine
development.
With
help
big
data,
AI
tries
to
mimic
cognitive
capabilities
a
human
brain,
such
as
problem-solving
learning
abilities.
Machine
Learning
(ML),
subset
AI,
holds
special
promise
for
solving
problems
based
experiences
gained
curated
data.
Advances
methods
have
created
an
unprecedented
opportunity
building
surveillance
systems
using
deluge
real-time
data
generated
within
short
span
time.
During
pandemic,
many
reports
discussed
utility
approaches
prioritization,
delivery,
supply
chain
drugs,
vaccines,
non-pharmaceutical
interventions.
This
review
will
discuss
clinical
AI-based
models
also
limitations
faced
by
systems,
model
generalizability,
explainability,
trust
pillars
real-life
deployment
healthcare.